OTCMKTS:MYRX - Myrexis Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0114 0.00 (0.00 %) (As of 12/10/2018 02:21 AM ET)Previous Close$0.0114Today's Range$0.0114 - $0.011452-Week Range$0.0114 - $0.0580Volume500 shsAverage Volume7,696 shsMarket Capitalization$390,000.00P/E RatioN/ADividend YieldN/ABeta-0.15 ProfileDiscussionChartDividendEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York. Receive MYRX News and Ratings via Email Sign-up to receive the latest news and ratings for MYRX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:MYRX Previous Symbol CUSIPN/A Webwww.myrexis.com Phone801-214-7800 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding Shares34,480,000Market Cap$390,000.00 OptionableNot Optionable Myrexis (OTCMKTS:MYRX) Frequently Asked Questions What is Myrexis' stock symbol? Myrexis trades on the OTCMKTS under the ticker symbol "MYRX." Has Myrexis been receiving favorable news coverage? News headlines about MYRX stock have trended somewhat positive recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Myrexis earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned news articles about the biopharmaceutical company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. Who are some of Myrexis' key competitors? Some companies that are related to Myrexis include Aoxing Pharmaceutical (AOXG), RXi Pharmaceuticals (RXII), GlobeImmune (GBIM), Cotinga Pharmaceuticals (COTQF), Affymax (AFFY), FutureWorld (FWDG), Tetralogic Pharmaceuticals (TLOG), Spotlight Innovation (STLT), Targeted Medical Pharma (TRGM), Aeolus Pharmaceuticals (AOLS), HST Global (HSTC), American Oriental Bioengineering (AOBI), Orexigen Therapeutics (OREXQ), Pivotal Therapeutics (PVTTF) and Poniard Pharmaceuticals (PARD). Who are Myrexis' key executives? Myrexis' management team includes the folowing people: Mr. Jonathan M. Couchman, Chairman, CEO, Pres, CFO and Principal Accounting Officer (Age 48) How do I buy shares of Myrexis? Shares of MYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Myrexis' stock price today? One share of MYRX stock can currently be purchased for approximately $0.0114. How big of a company is Myrexis? Myrexis has a market capitalization of $390,000.00. What is Myrexis' official website? The official website for Myrexis is http://www.myrexis.com. How can I contact Myrexis? Myrexis' mailing address is C/O XSTELOS HOLDINGS INC. 630 FIFTH AVENUE SUITE 2260, NEW YORK NY, 10020. The biopharmaceutical company can be reached via phone at 801-214-7800 or via email at [email protected] MarketBeat Community Rating for Myrexis (OTCMKTS MYRX)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 48 (Vote Outperform)Underperform Votes: 36 (Vote Underperform)Total Votes: 84MarketBeat's community ratings are surveys of what our community members think about Myrexis and other stocks. Vote "Outperform" if you believe MYRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYRX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/10/2018 by MarketBeat.com StaffFeatured Article: What are retained earnings?